Cryosite Past Earnings Performance
Past criteria checks 5/6
Cryosite has been growing earnings at an average annual rate of 25.4%, while the Life Sciences industry saw earnings growing at 19.6% annually. Revenues have been growing at an average rate of 11% per year. Cryosite's return on equity is 54.4%, and it has net margins of 12.5%.
Key information
25.4%
Earnings growth rate
24.5%
EPS growth rate
Life Sciences Industry Growth | 19.7% |
Revenue growth rate | 11.0% |
Return on equity | 54.4% |
Net Margin | 12.5% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Cryosite makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 13 | 2 | 5 | 0 |
30 Sep 23 | 12 | 1 | 5 | 0 |
30 Jun 23 | 12 | 1 | 5 | 0 |
31 Mar 23 | 12 | 1 | 5 | 0 |
31 Dec 22 | 12 | 1 | 5 | 0 |
30 Sep 22 | 12 | 1 | 5 | 0 |
30 Jun 22 | 12 | 1 | 4 | 0 |
31 Mar 22 | 11 | 1 | 4 | 0 |
31 Dec 21 | 11 | 1 | 4 | 0 |
30 Sep 21 | 10 | 1 | 4 | 0 |
30 Jun 21 | 10 | 1 | 4 | 0 |
31 Mar 21 | 10 | 1 | 4 | 0 |
31 Dec 20 | 10 | 1 | 5 | 0 |
30 Sep 20 | 9 | 1 | 5 | 0 |
30 Jun 20 | 9 | 1 | 4 | 0 |
31 Mar 20 | 9 | 2 | 4 | 0 |
31 Dec 19 | 8 | 2 | 3 | 0 |
30 Sep 19 | 8 | 1 | 3 | 0 |
30 Jun 19 | 8 | -1 | 3 | 0 |
31 Dec 18 | 7 | -2 | 3 | 0 |
30 Sep 18 | 6 | -1 | 3 | 0 |
30 Jun 18 | 6 | 0 | 3 | 0 |
31 Dec 17 | 6 | 0 | 3 | 0 |
30 Sep 17 | 6 | 0 | 3 | 0 |
30 Jun 17 | 6 | 0 | 3 | 0 |
31 Mar 17 | 7 | 0 | 3 | 0 |
31 Dec 16 | 8 | 0 | 3 | 0 |
30 Sep 16 | 9 | 0 | 3 | 0 |
30 Jun 16 | 10 | 0 | 4 | 0 |
31 Mar 16 | 10 | 0 | 4 | 0 |
31 Dec 15 | 9 | 0 | 4 | 0 |
30 Sep 15 | 10 | 0 | 4 | 0 |
30 Jun 15 | 10 | 0 | 4 | 0 |
31 Mar 15 | 10 | 0 | 4 | 0 |
31 Dec 14 | 10 | 1 | 4 | 0 |
30 Sep 14 | 9 | 1 | 4 | 0 |
30 Jun 14 | 9 | 1 | 4 | 0 |
31 Mar 14 | 9 | 1 | 4 | 0 |
31 Dec 13 | 9 | 1 | 3 | 0 |
30 Sep 13 | 9 | 1 | 4 | 0 |
30 Jun 13 | 8 | 1 | 4 | 0 |
Quality Earnings: CTE has high quality earnings.
Growing Profit Margin: CTE's current net profit margins (12.5%) are higher than last year (10.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CTE has become profitable over the past 5 years, growing earnings by 25.4% per year.
Accelerating Growth: CTE's earnings growth over the past year (25%) is below its 5-year average (25.4% per year).
Earnings vs Industry: CTE earnings growth over the past year (25%) exceeded the Life Sciences industry 0.5%.
Return on Equity
High ROE: CTE's Return on Equity (54.4%) is considered outstanding.